Buchumschlag

In which common chronic conditions can (or cannot) obesity and lifestyle factors explain higher concentrations of C‐reactive protein?

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jana J. Anderson, Salil V. Deo, Paul Welsh, Danny F. MacKay, Frederick K. Ho, Lyn D. Ferguson, Carlos Celis‐Morales, Jason M. R. Gill, Jill P. Pell, Naveed Sattar
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Diabetes, Obesity and Metabolism
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Association of glycaemic control with intraocular pressure in a large general population: Results from the UK Biobank
von: Qiaoling Liu, et al.
Veröffentlicht: (2024)

Progressive increases in adiposity and ectopic fat surrogates across glycaemic states highlight weight reduction as a key target for type 2 diabetes prevention, especially in younger people
von: Sabrina Scilletta, et al.
Veröffentlicht: (2025)

How would the use of Semaglutide impact the Chilean population? An estimated analysis following the SELECT trial approach
von: Fanny Petermann‐Rocha, et al.
Veröffentlicht: (2025)

The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
von: Iskandar Idris, et al.
Veröffentlicht: (2025)

When can weekly anti‐obesity peptides be used for monthly administration?
von: Daniel V. Santi
Veröffentlicht: (2024)

Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trial
von: Joanna Y. Gong, et al.
Veröffentlicht: (2025)

Degree of joint risk factor control and incident chronic kidney disease among individuals with obesity
von: Rui Tang, et al.
Veröffentlicht: (2024)

Long‐term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction‐associated fatty liver disease in adults with obesity and type 2 diabetes
von: Michelle D. Lundholm, et al.
Veröffentlicht: (2024)

Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019
von: Naomi Holman, et al.
Veröffentlicht: (2025)

Trends in hospitalization for cardio‐renal disease and mortality in people with type 1 diabetes in England, 2009–2019
von: Naomi Holman, et al.
Veröffentlicht: (2024)

Glycaemic Control by Sociodemographic Factors in Adults With Type 1 Diabetes in England: Trends From 2007–2008 to 2023–2024
von: Muhammad Saleem Khan, et al.
Veröffentlicht: (2026)

Risk stratification using coronary artery calcium and potential benefit of semaglutide therapy: A cost‐effectiveness modelling study
von: Sai Rahul Ponnana, et al.
Veröffentlicht: (2026)

Perceptions, attitudes and barriers to effective obesity care among people with obesity and health care professionals in India
von: A. G. Unnikrishnan, et al.
Veröffentlicht: (2024)

Association of combined healthy lifestyle with risk of adverse outcomes in patients with prediabetes
von: Xiaoqin Xu, et al.
Veröffentlicht: (2024)

Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE‐ O trial
von: Hertzel C. Gerstein, et al.
Veröffentlicht: (2024)

Obesity‐related distress and obesity burnout: Towards a conceptual framework for disease‐specific emotional burden in obesity
von: Katarzyna Cyranka, et al.
Veröffentlicht: (2026)

A predictive model for medium‐term weight loss response in people with type 2 diabetes engaging in behavioural weight management interventions
von: Lulwa Al‐Abdullah, et al.
Veröffentlicht: (2024)

Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial
von: Navdeep Tangri, et al.
Veröffentlicht: (2024)

An overview of obesity‐related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes
von: Matthias Blüher
Veröffentlicht: (2025)

Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes—The Steady Sugar trial
von: Karen Elkind‐Hirsch, et al.
Veröffentlicht: (2025)

The daunting task of recruiting insulin‐treated patients living with type 2 diabetes mellitus for intensive lifestyle interventions
von: Cathy J. Sun, et al.
Veröffentlicht: (2024)

Association of lifestyle with reduced stroke risk in 41 314 individuals with diabetes: Two prospective cohort studies in China
von: Jian Su, et al.
Veröffentlicht: (2024)

The role of incretin receptor agonists in the treatment of obesity
von: Thomas Forst, et al.
Veröffentlicht: (2024)

Ten‐year progression of obesity‐related complications in a population with overweight and obesity in the UK : A retrospective open cohort study
von: Jonathan Pearson‐Stuttard, et al.
Veröffentlicht: (2024)

Enhancing postpartum cardiometabolic health for women with previous gestational diabetes: Next steps and unanswered questions for pharmacological and lifestyle strategies
von: Rajna Golubic, et al.
Veröffentlicht: (2024)

Differential effects of lifestyle interventions on continuous glucose monitoring metrics in persons with type 2 diabetes: Potential for personalised treatment
von: Iris M. de Hoogh, et al.
Veröffentlicht: (2025)

Weight loss interventions and obesity‐associated cancers in people with type 2 diabetes and overweight/obesity: A real‐world observational study
von: Testimony Ipaye, et al.
Veröffentlicht: (2025)

Contribution of genetic and environmental factors to obesity indices and their overlap
von: Alireza Ani, et al.
Veröffentlicht: (2026)

Practical strategies to manage obesity in type 2 diabetes
von: Helena W. Rodbard, et al.
Veröffentlicht: (2024)

Cognitive reserve, genetic risk, and lifestyle in the incidence and progression of type 2 diabetes: A large community‐based longitudinal study
von: Shaojie Han, et al.
Veröffentlicht: (2025)

Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
von: Jia‐Jie Wang, et al.
Veröffentlicht: (2024)

Advancing brain health prevention using explainable CKM ‐based predictive modelling
von: Jiaxuan Li, et al.
Veröffentlicht: (2026)

Newly defined clinical obesity versus body mass index ‐defined obesity: Differential risks of overall death and adverse events in a population‐based cohort
von: Li‐You Lian, et al.
Veröffentlicht: (2025)

Glucagon‐like peptide‐1 receptor agonists and the risk of nonarteritic anterior ischaemic optic neuropathy: A systematic review and meta‐analysis of observational studies
von: Ronald M. Goldenberg, et al.
Veröffentlicht: (2025)

The melanocortin‐4 receptor pathway and the emergence of precision medicine in obesity management
von: Sima Fansa, et al.
Veröffentlicht: (2024)

The effects of anti‐obesity medications on bone metabolism: A critical appraisal
von: Athanasios D. Anastasilakis, et al.
Veröffentlicht: (2025)

Higher plasma dicarbonyl levels are associated with liver fibrosis in obese individuals
von: Oluwatomisono I. Akinrimisi, et al.
Veröffentlicht: (2025)

Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
von: Ebaa Al‐Ozairi, et al.
Veröffentlicht: (2024)

Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes
von: Thomas Nyström, et al.
Veröffentlicht: (2024)

Tirzepatide in the NHS : The known unknowns of treating obesity at a national scale
von: Ashley Kieran Clift, et al.
Veröffentlicht: (2025)